Purpose: To determine the efficacy and safety of infliximab in the treatment of refractory posterior uveitis.
Design: Noncomparative interventional case series.
Participants: Five patients with posterior uveitis were treated: 3 had Behçet's syndrome, and 2 had idiopathic posterior uveitis.